Source link : https://newshealth.biz/health-news/major-complete-response-rate-in-very-high-risk-bladder-cancer-with-combo-treatment/
WASHINGTON — Adding immunotherapy to standard treatment for non-muscle invasive bladder cancer (NMIBC) achieved complete response (CR) in more than 90% of patients who had refused cystectomy for high-risk disease, a small prospective study showed. Only three of 37 patients did not have a CR at 6 months with pembrolizumab (Keytruda) and Bacille Calmette-Guérin (BCG). […]
The post Major Complete Response Rate in Very High-Risk Bladder Cancer With Combo Treatment first appeared on News Health.
—-
Author : News Health
Publish date : 2026-05-17 21:17:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8